ArticleFrontiers in bioengineering and biotechnology2020

Albumin-Modified Melanin-Silica Hybrid Nanoparticles Target Breast Cancer Cells via a SPARC-Dependent Mechanism.

Gennaro Sanità et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.